JFrog stock rises as Cantor Fitzgerald maintains Overweight rating after strong Q2
Albertsons Companies, Inc. (NYSE:ACI), a prominent player in the Consumer Staples sector with over $81 billion in annual revenue and a market capitalization of $10.67 billion, reported the results of its 2025 annual meeting of stockholders held Thursday, according to a statement based on a recent SEC filing.
Shareholders elected all nominated directors to serve until the 2026 annual meeting. The elected directors are Sharon Allen, Frank Bruno, James Donald, Kim Fennebresque, Allen Gibson, Lisa Gray, Sarah Mensah, Susan Morris, Alan Schumacher, Brian Kevin Turner, and Mary Elizabeth West.
In other business, shareholders ratified the appointment of Deloitte & Touche LLP as the company’s independent registered public accounting firm for the fiscal year ending February 28, 2026. The ratification received 508,402,571 votes in favor, 5,294,741 against, and 880,912 abstentions.
An advisory vote on executive compensation was approved, with 460,283,632 votes for, 14,137,993 against, and 1,352,727 abstaining.
Stockholders voted on several proposals submitted by shareholders. A proposal requesting Albertsons to disclose specific food waste measurements was not approved, receiving 38,627,239 votes in favor and 434,542,262 against. A proposal for a report on the company’s human rights policy and due diligence process was also not approved, with 50,116,337 votes for and 423,073,242 against. Additionally, a proposal requesting a report on risks of state policies restricting reproductive health care was not approved, with 21,612,709 votes for and 449,458,807 against.
The information is based on a press release statement included in the company’s SEC filing.
In other recent news, Albertsons Companies reported its Q1 2025 earnings, revealing an adjusted earnings per share (EPS) of $0.55, which aligned with analysts’ expectations. The company’s revenue slightly exceeded forecasts, coming in at $24.88 billion compared to the anticipated $24.68 billion. Additionally, UBS has upgraded Albertsons stock from Neutral to Buy, setting a new price target of $27.00, up from $22.00. The investment bank highlighted the company’s potential growth in pharmacy and digital sectors as key factors for this upgrade. UBS also provided adjusted EPS estimates for Albertsons that are 4% above the consensus for fiscal year 2026 and 8% higher for fiscal year 2027. These developments indicate a positive outlook from analysts on Albertsons’ future performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.